Continuous abstinence rates from months 2 to 6 in the per protocol population^*.

CI Confidence interval. Ab Antibody titers. *nicotine replacement therapy users and subjects with missing titers were excluded; the participants on active treatment were separated into three responder groups according to their antibody (Ab) titers: high, medium, and low antibody titer levels. **vs. placebo.